Shares of Novacyt S.A. (LON:NCYT – Get Free Report) rose 16% on Wednesday . The stock traded as high as GBX 58 ($0.74) and last traded at GBX 58 ($0.74). Approximately 849,279 shares were traded during mid-day trading, an increase of 62% from the average daily volume of 522,714 shares. The stock had previously closed at GBX 50 ($0.64).
Novacyt Stock Up 18.0 %
The firm has a market cap of £41.67 million, a price-to-earnings ratio of -96.15 and a beta of -1.86. The business’s 50-day moving average is GBX 53.43 and its 200-day moving average is GBX 58.52. The company has a debt-to-equity ratio of 18.67, a quick ratio of 4.46 and a current ratio of 4.04.
About Novacyt
Novacyt SA, together with its subsidiaries, provides in vitro and molecular diagnostic tests for a range of infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Lab21 Products, and IT-IS International segments.
Featured Articles
- Five stocks we like better than Novacyt
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- The Great CPU Race: AMD and Intel Battle for Dominance
- 5 Top Rated Dividend Stocks to Consider
- GameStop Turns a Profit: So What? It’s Still Not Worth Investing
- Market Cap Calculator: How to Calculate Market Cap
- C3.ai Stock Surges on Strong Sales Despite Profit Concerns
Receive News & Ratings for Novacyt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novacyt and related companies with MarketBeat.com's FREE daily email newsletter.
